Controlling, Mapping, and Modeling Neural Circuits

## Why brains are opaque Brain tissue scatters light, mostly because of **lipids** in cell membranes. Traditionally, researchers sliced brains into thin sections, imaged each one, and tried to reassemble the 3D picture — slow, and error-prone for long-range connections. ## The CLARITY idea CLARITY makes fixed tissue transparent while keeping its molecules in place: 1. **Biomolecules of interest + hydrogel framework → stabilized tissue information.** Proteins and nucleic acids are linked to a hydrogel mesh formed inside the tissue. 2. **Lipid removal → reduced light scattering.** Lipids, not anchored to the mesh, are removed. 3. **Optical access to intact tissue.** Light can now pass deep into the sample, and labels can be imaged in 3D. ## What it enables - **3D anatomy** of whole brains or large tissue blocks - **Long-range projections** traced continuously rather than across slices - **Cellular distributions** — where particular cell types sit - **Molecular labels** — antibodies and probes for specific proteins or RNA ## Structure versus function CLARITY is primarily a **structural and molecular** method applied to **fixed (non-living) tissue**. It shows where cells, projections, and molecules are. It does **not** record live neural activity. To know what neurons were *doing*, researchers combine it with activity measurements (such as electrophysiology or calcium imaging) or with molecular activity markers captured before fixation. This is the map–record distinction in the course framework: CLARITY maps; recordings measure dynamics. The two are complementary. ## The course framework GENES → CELL TYPES → CIRCUITS → NETWORK DYNAMICS → BEHAVIOR, studied by four complementary approaches: **map**, **record**, **perturb**, and **model**. Understanding a neural circuit requires several of these ways of observing and testing the same biological system. ## Further reading - [Deisseroth Lab (Stanford)](https://web.stanford.edu/group/dlab/) - Developmental xenocortication using human-derived organoids in mice. *Nature* (2026) — collaborative work by multiple Stanford groups and investigators.